Back to search

Article

Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives

2020-11-10

Abstract excerpt

Current anticancer drug discovery and development efforts are aimed at identifying new complexes that can potently and selectively target DNA and modulate the functions of target proteins. Tin complexes, categorized as monoorganotin (RSnL 3 ), diorganotin (R 2 SnL 2 ), triorganotin (R 3 SnL), or tetraorganotin (R 4 SnL), are one of the most studied complexes in the metal‐based anticancer drug discovery and develop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f1bf39f-fd0a-514f-b307-c73412ce7fa8
DOI
10.1002/aoc.6089
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectivesDOI 10.1002/aoc.6089
Select a neighboring publication to make it the new centre.